Ascorbic acid potentiates mitomycin C-induced micronuclei and sister chromatid exchanges in human peripheral blood lymphocytes in vitro

Teratogenesis Carcinogenesis and Mutagenesis

Volumn , Issue SUPPL. 1, 2003, Pages 99-112

  Krishnaja, A P ^a   Sharma, N K ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Antineoplastic agent; CBMN assay; Chromosome damage; Genotoxicity; Human lymphocytes; Micronuclei; Sister chromatid exchanges; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; DNA; METAL ION; MITOMYCIN C; OXYGEN RADICAL;

AUTOOXIDATION; CELL DIVISION; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GENOTOXICITY; HUMAN; HUMAN CELL; MICRONUCLEUS; MODULATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

EID: 0037289196     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/tcm.10064     Document Type: Conference Paper

References (48)

1. Shamberger RJ. Genetic toxicology of ascorbic acid. Mutat Res 1984;133:135-159.
2. Gershoff SN. Vitamin C (Ascorbic acid): new roles, new requirements? Nutr Rev 1993;51:313-326.
3. Block G, Schwarz R. Ascorbic acid and cancer: animal and cell culture data. In: Helmut S, editor. Antioxidants in health and disease. New York: Academic Press; 1994. p 129-155.
4. Anderson D. Antioxidant defenses against reactive oxygen species causing genetic and other damage. Mutat Res 1996;350:103-108.
5. Odin AP. Vitamins as antimutagens: advantages and some possible mechanisms of antimutagenic action. Mutat Res 1997;386:39-67.
6. Antunes LMG, Araujo MCP, Dari JDC, Bianchi MLP. Effect of the antioxidants curcumin and Vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cell. Mutat Res 2000;465:131-137.
7. Hercberg S, Galan P, Preziosi P, Roussel AM, Arnaud J, Richard MJ, Malvy D, Paul-Dauphin A, Briancon S, Favier A. Background and rationale behind the SU.VI.MAX Study. A prevention trial using nutrional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancer. Int J Vitam Nutr Res 1998;68:3-20.
8. Gentil JM, Rahimi S, Zwiesler J, Gentile GJ, Ferguson LR. Effect of selected antimutagens on the genotoxicity of antitumor agents. Mutat Res 1998;402:289-298.
9. Antunes LMG, Takahashi CS. Protection and induction of chromosomal damage by Vitamin C in human lymphocyte cultures. Teratogenesis Carcinog Mutagen 1999;19:53-59.
10. Nefic H. Anticlastogenic effect of Vitamin C on cisplatin induced chromosome aberrations in human lymphocyte cultures. Mutat Res 2001;498:89-98.
11. Konopacka M, Rzeszowska-Wolny J: Antioxidant Vitamins C, E and B-carotene reduce DNA damage before as well as after gamma ray irradiation of human lymphocytes in vitro. Mutat Res 2001;491:1-7.
12. Galloway SM, Painter RB. Vitamin C is positive in the DNA synthesis inhibition and sister-chromatid exchange tests. Mutat Res 1979;60:321-327.
13. Stich HF, Wei L, Whiting RF. Enhancement of the chromosome-damaging action of ascorbate by transition metals. Cancer Res 1979;39:4145-4151.
14. Rosin MP, San RHC, Stich HF: Mutagenic activity of ascorbate in mammalian cell cultures. Cancer Lett 1980;8:299-305.
15. Speit G, Wolf M, Vogel W. The SCE-inducing capacity of Vitamin C: investigations in vitro and in vivo. Mutat Res 1980;78:273-278.
16. Norkus EP, Kuenzig W, Conney AH. Studies on the mutagenic activity of ascorbic acid in vitro and in vivo. Mutat Res 1983;117:83-191.
17. David Josephy P, Palcic B, Skarsgard LD. Ascorbate-enhanced cytotoxicity of misonidazole. Nature 1978;271:370-372.
18. Lialiaris T, Mourelatos D, Dozi-Vassiliades J. Enhancement and attenuation of cytogenetic damage by vitamin C in cultured human lymphocytes exposed to Thiotepa or L-ethionine. Cytogenet Cell Genet 1987;44:209-214.
19. Krishnaja AP, Sharma NK. Heterogeneity of chromosome damage in B-thalassaemia traits. An evaluation of spontaneous and gamma ray induced micronuclei and chromosome aberrations in lymphocytes in vitro after G0 and G2 phase irradiation. Int J Radiat Biol 1994;66:29-39.
20. Sharma, NK, Krishnaja AP. Enhancement of mitomycin C induced micronuclei and sister chromatid exchanges by ascorbic acid (vitamin C) in human lymphocytes in vitro. DAE symposium on recent advances in genetic epidemiology and population monitoring. Book of abstracts. Chennai: EMSI. p 38, 1998.
21. Krishnaja AP, Sharma NK. On the optimization and application of sister chromatid exchanges (SCEs) and cytokinesis blocked micronuclei (CBMN) in human lymphocytes for cytogenetic monitoring. In: Chauhan PS, Gopinath PM, editors. Environmental mutagenesis and carcinogenesis. Mumbai: Quest Publications; 1998. p 77-90.
22. Sharma, NK, Krishnaja AP. Modified SCE and CBMN assays in human lymphocytes for cytogenetic studies. National symposium on environmental genotoxins, low level exposures and biological effects and XXI Annual Conference of EMSI. Book of abstracts. Madras: EMSI. p 45, 1996.
23. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993;285:35-44.
24. Lamberti L, Ponzetto PB, Ardito G. Cell kinetics and sister chromatid exchange frequency in human lymphocytes. Mutat Res 1983;120:193-199.
25. Ames BN. Dietary carcinogens and anticarcinogens. Science 1983;221:1256-1264.
26. Halliwell B: Vitamin C and genomic stability. Mutat Res 2001;475:29-35.
27. Konopacka M, Widel M, Rzeszowska-Wolny J. Modifying effect of vitamins C, E and beta-carotene against gamma-ray induced DNA damage in mouse cells. Mutat Res 1998;417:85-94.
28. Fenech M, Rinaldi J. The relationship between micronuclei in human lymphocytes and plasma levels of Vitamin C, Vitamin E, Vitamin B12 and folic acid. Carcinogenesis 1994;15:1405-1411.
29. Odagiri Y, Uchida H. Influence of serum micronutrients on the incidence of kinotochore-positive or negative micronuclei in human peripheral blood lymphocytes. Mutat Res 1998;415:35-45.
30. Yew ML. Megadose vitamin C supplementation and ascorbic acid and dehydroascorbic acid levels in plasma and lymphocytes. Nutr Rep Int 1984;30:597-601.
31. MacGregor JT, Wehr CM, Hiatt RA, Peters B, Tucker JD, Langlois RG, Jacob RA, Ames BN. Spontaneous genetic damage in man: evaluation of inter-individual variability, relationship among markers of damage, and influence of nutritional status. Mutat Res 1997;377:125-135.
32. Huber R, Braselmann H, Bauchinger M. Screening for interindividual differences in radiosensitivity by means of the micronucleus assay in human lymphocytes. Int J Radiat Biol 1992;61:655-661.
33. Odagiri Y, Uchida H, Schibazaki S. Interindividual variation in cytogenetic response to X-ray and colchicine measurement with the cytokinesis-block micronucleus assay. Mutat Res 1997;381:1-13.
34. Green MH, Lowe JE, Waugh APW, Aldridge KE, Cole J, Arlett CF. Effect of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutat Res 1994;316:91-102.
35. Schneider M, Diemer K, Engelhart K, Zankl H, Trommer WE, Biesalski HK. Protective effects of vitamins C and E on the number of micronuclei in lymphocytes in smokers and their role in ascorbate free radical formation in plasma. Free Radic Res 2001;34:209-219.
36. Crott JW, Fenech M. Effect of Vitamin C supplementation on chromosome damage, apoptosis and necrosis ex vivo. Carcinogenesis 1999;23:1035-1041.
37. Prasad KN, Sinha PK, Ramanujam M, Sakamoto A. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci USA 1979;76:829-832.
38. Berger MR, Berger I, Schnahl D. Vitamins and cancer. In: Berger MR, Berger I, editors. Nutrition, toxicity and cancer. Boca Raton: CRC Press; 1992. p 517-548.
39. Wayner DDM, Burton GW, Ingold KU. The antioxidant efficiency of Vitamin C is concentration dependent. Biochem Biophys Acta 1986;884:119-123.
40. Cooke MS, Evans MD, Podmore ID, Herbert KE, Mistry N, Mistry P, Hickenbotham PT, Hussieni A, Griffith HR, Lunec J. Novel repair action of Vitamin C upon in vitro oxidative DNA damage. FEBS Lett 1998;363:363-367.
41. Bodo M, Todisco T, Pezzetti F, Dottorini M, Moggi L, Becchetti E. Ability of retinoic and ascorbic acid to interfere with the binding of benzo(a)pyrene to DNA in explants from donors with bronchial cancer. Oncology 1989;46:178-182.
42. Edgar JA. Ascorbic acid and biological alkylating agents. Nature 1974;248:136-137.
43. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559.
44. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo? Free Rad Res 1996;25:439-454.
45. Halliwell B. Vitamin C: poison, prophylactic or panacea? TIBS 1999;24:255-259.
46. 2. Antiox Redox Signal 2001;3:157-163.
47. Anderson D. Factors that contribute to biomarker responses in humans including a study in individuals taking Vitamin C supplemetation. Mutat Res 2001;480:337-347.
48. Elsendoorn TJ, Weijl NI, Mithoe S, Zwinderman AH, Van Dam F, De Zwart FA, Tates AD, Osanto S. Chemotheapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat Res 2001;498:145-158